Bay City Capital
Bay City Capital LLC, founded in 1997 and based in San Rafael, California, is a private equity firm that specializes in managing investment funds within the life sciences sector. The firm has overseen six venture funds, collectively representing $1.5 billion in capital, and has invested in over 70 companies. Its investment focus encompasses a range of areas including biopharmaceuticals, drug discovery, medical devices, nutrition, healthcare IT, and medical diagnostics. Bay City Capital's approach aims to support innovative companies that contribute to advancements in healthcare and life sciences.
Bridge Medicines LLC offers drug discovery services. It focuses on developing technologies in academic institutions from human proof-of-concept to clinical development. The company develops inhibitors of ENL-YEATS for the treatment of acute leukemias, such as acute myelogenous leukemia and a series of orally active small molecule inhibitors of activated factor XII for the treatment of hereditary angioedema and other inflammatory disorders. Bridge Medicines LLC was founded in 2016 and is based in New York, New York.
Bridge Medicines LLC offers drug discovery services. It focuses on developing technologies in academic institutions from human proof-of-concept to clinical development. The company develops inhibitors of ENL-YEATS for the treatment of acute leukemias, such as acute myelogenous leukemia and a series of orally active small molecule inhibitors of activated factor XII for the treatment of hereditary angioedema and other inflammatory disorders. Bridge Medicines LLC was founded in 2016 and is based in New York, New York.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.